SCPS
NASDAQScopus BioPharma Inc.
Latest news
25 items- SECSEC Form 1-Z filed by Scopus BioPharma Inc.1-Z - Scopus BioPharma Inc. (0001772028) (Filer)
- SECSEC Form 15-12G filed by Scopus BioPharma Inc.15-12G - Scopus BioPharma Inc. (0001772028) (Filer)
- PRScopus BioPharma's Subsidiary — Duet BioTherapeutics — Presents Compelling New Data for a Novel Treatment for Malignant Glioma at 38th Annual Meeting of the Society for Immunotherapy of CancerDUET-102 in Combination with PD-1 Blockade Demonstrates Significant Anti-Tumor Activity in Models of Malignant Glioma Data Suggests Benefits of Combinations of DUET-102 with Other T-Cell Based Immunotherapies, such as CAR-Ts NEW YORK, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Scopus BioPharma Inc. (OTCQB: "SCPS") and its majority-owned subsidiary, Duet BioTherapeutics Inc., presented compelling new data that DUET-102 in combination with PD-1 blockade demonstrates significant anti-tumor activity in models of malignant glioma. The new data was presented on November 4, 2023 at the 38th Annual Meeting of the Society for Immunotherapy of Cancer ("SITC") by Marcin Kortylewski, Ph.D. Dr. Kortylewski,
- PRScopus BioPharma's Subsidiary — Duet BioTherapeutics — to Present at the 38th Annual Meeting of the Society for Immunotherapy of CancerNEW YORK, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Scopus BioPharma Inc. (OTCQB: "SCPS"), a biotechnology company developing transformational therapeutics for serious diseases with significant unmet medical need, and its subsidiary, Duet BioTherapeutics Inc., which is developing novel immunotherapies to overcome treatment-resistant cancers, today announced that Marcin Kortylewski, Ph.D., Co-Founder and Senior Scientific Advisor of Duet and Professor of Immuno-Oncology at City of Hope, will be presenting at the 38th Annual Meeting of the Society for Immunotherapy of Cancer ("SITC"). SITC is being held from November 3-5, 2023, in San Diego, California. Details of the presentation are as follows:
- SECScopus BioPharma Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits8-K - Scopus BioPharma Inc. (0001772028) (Filer)
- SECScopus BioPharma Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - Scopus BioPharma Inc. (0001772028) (Filer)
- SECSEC Form 10-Q filed by Scopus BioPharma Inc.10-Q - Scopus BioPharma Inc. (0001772028) (Filer)
- SECSEC Form DEF 14A filed by Scopus BioPharma Inc.DEF 14A - Scopus BioPharma Inc. (0001772028) (Filer)
- SECSEC Form PRER14A filed by Scopus BioPharma Inc.PRER14A - Scopus BioPharma Inc. (0001772028) (Filer)
- SECSEC Form 10-Q filed by Scopus BioPharma Inc.10-Q - Scopus BioPharma Inc. (0001772028) (Filer)
- SECSEC Form 10-K/A filed by Scopus BioPharma Inc. (Amendment)10-K/A - Scopus BioPharma Inc. (0001772028) (Filer)
- SECSEC Form 10-K filed by Scopus BioPharma Inc.10-K - Scopus BioPharma Inc. (0001772028) (Filer)
- SECSEC Form NT 10-K filed by Scopus BioPharma Inc.NT 10-K - Scopus BioPharma Inc. (0001772028) (Filer)
- SECSEC Form 25-NSE filed by Scopus BioPharma Inc.25-NSE - Scopus BioPharma Inc. (0001772028) (Subject)
- NEWS12 Health Care Stocks Moving In Tuesday's Intraday SessionGainers Jasper Therapeutics (NASDAQ:JSPR) shares moved upwards by 576.1% to $3.27 during Tuesday's regular session. As of 12:30 EST, this security is trading at a volume of 39.7 million shares, making up 55465.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $121.0 million. Lucira Health (NASDAQ:LHDX) stock increased by 512.33% to $0.68. Trading volume for Lucira Health's stock is 119.7 million as of 12:30 EST. This is 35583.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $27.6 million. Reshape Lifesciences (NASDAQ:RSLS) shares moved upwards by 96.73% to $13.26. The cur
- NEWS12 Health Care Stocks Moving In Monday's Intraday SessionGainers Dermata Therapeutics (NASDAQ:DRMA) shares increased by 101.8% to $0.4 during Monday's regular session. As of 12:30 EST, this security is trading at a volume of 44.7 million shares, making up 5373.9% of its average full-day volume over the last 100 days. The company's market cap stands at $4.8 million. 180 Life Sciences (NASDAQ:ATNF) shares rose 79.36% to $3.39. Trading volume for this security as of 12:30 EST is 39.5 million, which is 2695.3% of its average full-day volume over the last 100 days. The company's market cap stands at $12.6 million. Palisade Bio (NASDAQ:PALI) stock increased by 61.46% to $5.2. Trading volume for this security as of 12:30 EST is 89.4 million, which is
- NEWS12 Health Care Stocks Moving In Thursday's Intraday SessionGainers Hoth Therapeutics (NASDAQ:HOTH) shares moved upwards by 143.4% to $10.71 during Thursday's regular session. As of 12:30 EST, this security is trading at a volume of 20.7 million shares, making up 17470.8% of its average full-day volume over the last 100 days. The company's market cap stands at $13.9 million. Quotient (NASDAQ:QTNT) shares increased by 93.95% to $0.45. Trading volume for Quotient's stock is 38.6 million as of 12:30 EST. This is 4861.7% of its average full-day volume over the last 100 days. The company's market cap stands at $1.5 million. Palisade Bio (NASDAQ:PALI) shares moved upwards by 53.59% to $2.78. The current volume of 6.2 million shares is 466.2% of Palisade
- NEWS12 Health Care Stocks Moving In Tuesday's Intraday SessionGainers Quotient (NASDAQ:QTNT) shares increased by 129.0% to $0.44 during Tuesday's regular session. As of 12:30 EST, Quotient's stock is trading at a volume of 20.9 million, which is 8106.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.5 million. 180 Life Sciences (NASDAQ:ATNF) stock rose 67.58% to $2.08. Trading volume for this security as of 12:30 EST is 43.9 million, which is 7441.9% of its average full-day volume over the last 100 days. The company's market cap stands at $4.2 million. HTG Molecular Diagnostics (NASDAQ:HTGM) shares moved upwards by 50.81% to $4.68. As of 12:30 EST, this security is trading at a volume of
- NEWS12 Health Care Stocks Moving In Monday's Intraday SessionGainers Scopus BioPharma (NASDAQ:SCPS) stock rose 50.0% to $0.12 during Monday's regular session. The current volume of 120.0K shares is 12.4% of Scopus BioPharma's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $2.5 million. NantHealth (NASDAQ:NH) shares increased by 28.55% to $3.6. The current volume of 183.6K shares is 205.1% of NantHealth's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $27.7 million. OncoCyte (NASDAQ:OCX) shares moved upwards by 27.29% to $0.38. The current volume of 1.0 million shares is 282.2% of OncoCyte's
- NEWS12 Health Care Stocks Moving In Friday's Intraday SessionGainers Immuron (NASDAQ:IMRN) shares increased by 37.9% to $2.22 during Friday's regular session. As of 12:30 EST, this security is trading at a volume of 17.1 million shares, making up 288523.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $12.6 million. Scopus BioPharma (NASDAQ:SCPS) shares increased by 25.0% to $0.1. As of 12:30 EST, this security is trading at a volume of 85.9K shares, making up 8.9% of its average full-day volume over the last 100 days. The company's market cap stands at $2.1 million. DBV Technologies (NASDAQ:DBVT) shares moved upwards by 21.18% to $1.43. As of 12:30 EST, DBV Technologies's stock is trading
- NEWSWhy AMC Entertainment Shares Are Trading Lower By Around 13%? Here Are 59 Stocks Moving In Thursday's Mid-Day SessionGainers Core Scientific, Inc. (NASDAQ:CORZ) shares jumped 188% to $0.1471. Core Scientific shares dipped 75% on Wednesday after the company filed for Chapter 11 bankruptcy. IsoPlexis Corporation (NASDAQ:ISO) rose 82.4% to $1.2598. Berkeley Lights announced plans to acquire IsoPlexis in all-stock transaction at $57.8 million. AMC Entertainment Holdings, Inc. (NYSE:APE) gained 77% to $1.21. AMC Entertainment Holdings Inc (NYSE:AMC) announced an equity capital raise and a debt for equity exchange. The company also proposed a vote to convert AMC Preferred Equity Units into common shares and enact a reverse stock split. ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) climbed 69% to $5.05 after the
- NEWS12 Health Care Stocks Moving In Thursday's Intraday SessionGainers IsoPlexis (NASDAQ:ISO) stock moved upwards by 131.1% to $1.59 during Thursday's regular session. Trading volume for IsoPlexis's stock is 33.5 million as of 12:30 EST. This is 80056.9% of its average full-day volume over the last 100 days. The company's market cap stands at $63.1 million. Scopus BioPharma (NASDAQ:SCPS) shares moved upwards by 76.61% to $0.11. As of 12:30 EST, this security is trading at a volume of 293.1K shares, making up 30.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $2.2 million. ORIC Pharmaceuticals (NASDAQ:ORIC) stock moved upwards by 55.56% to $4.67. The current volume of 25.5 million shares is
- NEWS12 Health Care Stocks Moving In Tuesday's Intraday SessionGainers Athenex (NASDAQ:ATNX) stock moved upwards by 41.4% to $0.19 during Tuesday's regular session. Trading volume for this security as of 12:30 EST is 112.5 million, which is 9232.0% of its average full-day volume over the last 100 days. The company's market cap stands at $30.0 million. Verona Pharma (NASDAQ:VRNA) stock rose 33.39% to $18.0. Trading volume for this security as of 12:30 EST is 12.3 million, which is 4920.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.3 billion. Surrozen (NASDAQ:SRZN) shares rose 18.72% to $0.57. As of 12:30 EST, this security is trading at a volume of 2.9 million shares, making up 916.4% o
- NEWSWhy Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day SessionGainers Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial. Axcella Health Inc. (NASDAQ:AXLA) shares rose 153% to $0.4105. Axcella Health shares dipped 63% on Friday after SVB Leerink downgraded the stock from Outperform to Market Perform and lowered its price target from $6 to $2. Camber Energy, Inc. (NYSE:CEI) shares climbed 103% to $0.1257 after the company announced an anticipated effective date of December 21, 2022 for its previously-announced 1-for-50 reverse stock split. Qumu Corporation (NASDAQ:QUMU) gained 98.2% to $0.8722 after Enghouse Systems anno
- NEWSStocks That Hit 52-Week Lows On MondayOn Monday, 297 companies reached new 52-week lows. Noteworthy Mentions In Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was Airbnb (NASDAQ:ABNB). The smallest company by market cap to set a new 52-week low was Baudax Bio (NASDAQ:BXRX). HEXO (NASDAQ:HEXO) made the largest move down on the session, with shares plummeting 1179.66% to reach its 52-week low. Marathon Digital Holdings (NASDAQ:MARA)'s stock rebounded the most, as it traded up 0.0% after dropping to a new 52-week low. Here is a list of stocks that set new 52-week lows on Monday: Brookfield (NYSE:BN) stock dropped to a yearly low on Monday of $31.79. Shares traded down 1.3%. Capital
SCPS FAQ
6 questionsWhat does Scopus BioPharma Inc. do?
Scopus BioPharma Inc., a biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases. Its lead development programs are immuno-oncology gene therapy for the treatment of various cancers, which include CO-sTiRNA, a STAT3 inhibitor gene therapy that drives tumor cell growth and anti-tumor immune suppression; and MRI-1867, a cannabinoid-1 receptor inverse agonist and inhibitor of inducible nitric oxide synthase for the treatment of systemic sclerosis. Scopus BioPharma Inc. has strategic partnerships with the City of Hope, National Institutes of...Where does SCPS stock trade?
Scopus BioPharma Inc. (SCPS) is listed on NASDAQ.What sector and industry is SCPS in?
Scopus BioPharma Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.When did Scopus BioPharma Inc. go public?
Scopus BioPharma Inc. (SCPS) completed its IPO in 2020.What companies are similar to SCPS?
Notable peers in the same industry include LLY (Eli Lilly and Company), AZN (AstraZeneca PLC), JNJ (Johnson & Johnson), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.). Compare SCPS side-by-side with any of them on Quantisnow.How can I track SCPS on Quantisnow?
Quantisnow aggregates Scopus BioPharma Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow SCPS to receive live email and push alerts on every new disclosure.